Rare bleeding disorders: Real-world data from a Spanish tertiary hospital
Blood Cells, Molecules, and Diseases · 2024
DOI: 10.1016/j.bcmd.2024.102837 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood Cells, Molecules, and Diseases, 2024. Verfasst von Daniel Martínez-Carballeira und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain; Platelet Research Lab, Instituto de Investigación S…. Hauptthemen laut MEDLINE: Blood Coagulation Disorders, Factor XI Deficiency. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
INTRODUCTION: Due to their low prevalence, rare bleeding disorders (RBDs) remain poorly characterized. AIM: To gain insight of RBDs through our clinical practice. METHODS: Retrospective study of the medical records of RBD patients followed up at the Central University Hospital of Asturias between January 2019 and December 2022. RESULTS: A total of 149 patients were included. Factor (F) VII (44 %) and FXI (40 %) deficiencies were the most common diagnosed coagulopathies. Most of the patients were asymptomatic (60.4 %) and the most frequent type of bleeding were mucocutaneous and after surgery. All replacement treatments were administered on demand and no patient was on a prophylaxis regimen. Currently available products were safe; allergic reactions after administration of plasma were the most frequent complication. Genetic analysis, carried out on 55 patients (37 %), showed that the most frequent mutations in RBDs are of missense type (71.9 %). We identified 11 different novel genetic alterations in affected genes. The c.802C > T (p.Arg268Cys) variant, previously described, was identified in 71 % (15 of 21) of the patients with FXI deficiency genotyped and none were related (probable founder effect). CONCLUSION: Our study on an unusual large single center cohort of RBD patients portrays location-dependent distinct genetic drives and clinical practice particularities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain; Platelet Research Lab, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain. Elect…
- Department of Hematology, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain; Platelet Research Lab, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.
- Department of Hematology, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain.
- Platelet Research Lab, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain; Department of Medicine, University of Oviedo, 33006 Oviedo, Spain.
Zitieren
APA
Martínez-Carballeira, D., Caro, A., Bernardo, Á., Corte, J. R., Iglesias, J. C., Hernández de Castro, I. A., Gutiérrez, L., & Soto, I. (2024). Rare bleeding disorders: Real-world data from a Spanish tertiary hospital. Blood Cells, Molecules, and Diseases. https://doi.org/10.1016/j.bcmd.2024.102837
Vancouver
Martínez-Carballeira D, Caro A, Bernardo Á, Corte JR, Iglesias JC, Hernández de Castro IA, et al. Rare bleeding disorders: Real-world data from a Spanish tertiary hospital. Blood Cells, Molecules, and Diseases. 2024. doi:10.1016/j.bcmd.2024.102837
BibTeX
@article{MartnezCarballeira2024,
author = {Martínez-Carballeira, Daniel and Caro, Alberto and Bernardo, Ángel and Corte, José Ramón and Iglesias, José Carlos and Hernández de Castro, Isabel Asunción and Gutiérrez, Laura and Soto, Inmaculada},
title = {Rare bleeding disorders: Real-world data from a Spanish tertiary hospital},
journal = {Blood Cells, Molecules, and Diseases},
year = {2024},
doi = {10.1016/j.bcmd.2024.102837}
}
EUVIMED